$879 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone-refractory prostate cancer$

879 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone-refractory prostate cancer

A. Heidenreich; C. Ohlmann; P. Olbert; A. Hegele

发现好书期刊，享受阅读乐趣